Core Laboratories Inc.
CLBEnergyNASDAQOil & Gas Equipment & Services
Scan Results
Daily timeframeCore Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. The $522.7M market capitalization puts CLB squarely in small-cap range for its industry. It operates through Reservoir Description and Production Enhancement segments.
Market Cap
$522.7M
Beta
1.01
P/E (TTM)
18.90
P/E (Fwd)
16.80
EPS (TTM)
$0.60
EPS (Fwd)
$0.68
ROE
11.1%
ROA
4.9%
Cash
$22.8M
Total Debt
$167.8M
Free CF
$44.2M
52W Change
-0.5%
Annual Financials
Cash vs Debt
On the balance sheet, CLB has $22.8M in cash with $167.8M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $44.2M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 11.1% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.9% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $489.7M (2022) to $526.5M (2025).
Core Laboratories Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing CLB's risk profile alongside its fundamentals and technical indicators provides a more complete picture.